<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Curr Glaucoma Pract</journal-id><journal-id journal-id-type="iso-abbrev">J Curr Glaucoma Pract</journal-id><journal-id journal-id-type="publisher-id">JOCGP</journal-id><journal-title-group><journal-title>Journal of Current Glaucoma Practice</journal-title></journal-title-group><issn pub-type="ppub">0974-0333</issn><issn pub-type="epub">0975-1947</issn><publisher><publisher-name>Jaypee Brothers Medical Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9385388</article-id><article-id pub-id-type="doi">10.5005/jp-journals-10078-1366</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Trabeculectomy Efficacy in a Latin American Ophthalmology Training Institution</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>L&#x000f3;pez</surname><given-names>Rafael AG</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Castillo</surname><given-names>Nora LO</given-names></name><xref rid="aff1" ref-type="aff">2</xref></contrib></contrib-group><aff id="aff1">
<label>1,2</label> Department of Ophthalmology, Benem&#x000e9;rito Comit&#x000e9; Pro-Ciegos Y Sordos De Guatemala, Guatemala</aff><author-notes><corresp id="cor1">Rafael AG L&#x000f3;pez, Department of Ophthalmology, Benem&#x000e9;rito Comit&#x000e9; Pro-Ciegos Y Sordos De Guatemala, Guatemala, Phone: +502 50321758, e-mail: <email>rafaelgabela360@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Apr</season><year>2022</year></pub-date><volume>16</volume><issue>1</issue><fpage>17</fpage><lpage>19</lpage><permissions><copyright-statement>Copyright &#x000a9; 2022; The Author(s).</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>&#x000a9; The Author(s). 2022 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract><title>A<sc>bstract</sc></title><sec><title>Aim</title><p>To report trabeculectomy efficacy in a Latin American Ophthalmology Training Institution.</p></sec><sec><title>Materials and methods</title><p>Retrospective study between March 2015 and March 2019, Medical records of 77 patients (96 eyes) that underwent trabeculectomy were reviewed. Collected data included glaucoma type, pre- and post-trabeculectomy intraocular pressure (IOP) and glaucoma therapy and assigned surgeon. Data analysis included descriptive statistics, Paired T student double tailed, and Welch-Satterthwaite test.</p></sec><sec><title>Results</title><p>Ninety-six eyes (77 patients) that underwent trabeculectomy were included in the analysis. 44.79% were male and 55.20% female. Median age was 54.04 &#x000b1; 18.92 years. Median IOP pretrabeculectomy was 27.86 &#x000b1; 10 mm Hg. More commonly found diagnoses were narrow angle glaucoma (36.46%), primary open-angle glaucoma (18.75%), and secondary to chronic steroid use glaucoma (14.58%). Median IOP reduction from basal IOP at 6 weeks, 6 months, and 12 months after trabeculectomy was 15.87 mm Hg, 14.42 mm Hg and 14.55 mm Hg, respectively, <italic>p</italic> &#x0003c; 0.05. Cumulative success was 66.66% at 12 months follow-up. General decrease of antiglaucomatous topical therapy was 1.9 &#x000b1; 1.09 (<italic>p</italic> &#x0003e; 0.05) eye drops. Trabeculectomy success rate was 69.23% for attendants and 65.71% for residents (<italic>p</italic> = 0.85).</p></sec><sec><title>Conclusion</title><p>Trabeculectomy continues to be a successful and effective therapy to obtain significant and stable IOP decrease. Success trabeculectomy rates are comparable between residents and attendants.</p></sec><sec><title>How to cite this article</title><p>L&#x000f3;pez RAG, Castillo NLO. Trabeculectomy Efficacy in a Latin American Ophthalmology Training Institution. J Curr Glaucoma Pract 2022;16(1):17-19.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>Glaucoma therapy</kwd><kwd>Latin America</kwd><kwd>Residents</kwd><kwd>Trabeculectomy efficacy</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>I<sc>ntroduction</sc></title><p>Glaucoma is a multifactorial irreversible disease that manifests with structural and functional damage to the optic nerve (ON). It is globally considered to be the first cause of irreversible blindness, so an early and effective diagnosis is required.<sup><xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref></sup></p><p>Glaucoma is defined as an intraocular pressure (IOP) rise above 21 mm Hg associated with progressive structural glaucomatous damage to the ON and characteristic visual field defects.<sup><xref rid="B3" ref-type="bibr">3</xref></sup></p><p>Initial glaucoma management consists of topical medical therapy and is aimed to achieving a sustained and stable decrease in IOP. Management and target IOP should be individualized for each patient, a 20&#x02013;30% decrease from basal IOP is sometimes required. Target IOP depends on various factors like disease stage, basal IOP, life expectancy, risk factors, and progression rate, being necessary to constantly monitor the amount of IOP decrease searched for.<sup><xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref></sup></p><p>Trabeculectomy is the gold standard surgical management for glaucoma, which consists in decreasing IOP by the creation of a drainage route for aqueous flow redirection. Trabeculectomy can be considered the first line therapy to stop disease progression in advanced glaucoma with significant visual field loss. Trabeculectomy is more effective in nontreated eyes.<sup><xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B4" ref-type="bibr">4</xref></sup></p><p>The aim of this study is to report trabeculectomy efficacy in a Latin American (Guatemalan) Ophthalmology Training Institution which is a national reference center for glaucoma management.</p></sec><sec sec-type="materials|methods"><title>M<sc>aterials and</sc> M<sc>ethods</sc></title><p>A retrospective study was conducted in the glaucoma unit of a Latin American Training Institution between March 2015 and March 2019.</p><p>The study was approved by the institutional review board and a written informed consent was signed by each patient. All participants were treated according to Helsinki Declaration.</p><p>Medical records of 77 patients (96 eyes) that underwent trabeculectomy were reviewed. Demographic data such as sex and age were collected. Further collected data included glaucoma type, preoperative IOP, postoperative IOP, preoperative number of topical medications, postoperative number of topical medications and healthcare provider who performed the surgery (resident/attendant), central corneal thickness, 30&#x000b0; visual field mean deviation, and cup/disk ratio. Two patients that failed to follow-up were excluded.</p><p>
<bold>Trabeculectomy success was defined as:</bold>
</p><list list-type="bullet"><list-item><p>Basal IOP reduction &#x02265;30% at 12 months follow-up without topical glaucoma therapy (total success)</p></list-item><list-item><p>Basal IOP reduction &#x02265;30% at 12 months with 1 or 2 topical glaucoma medications (partial success).</p></list-item></list><sec><title>Surgical Technique</title><p>When surgery was performed by residents, they did it under the supervision of experienced glaucoma attending:</p><list list-type="bullet"><list-item><p>IOP measurement with applanation tonometer (Schi&#x000f6;tz)</p></list-item><list-item><p>General anesthesia</p></list-item><list-item><p>Asepsis and antisepsis</p></list-item><list-item><p>A 5% povidone iodine in lower fornix (1 minute)</p></list-item><list-item><p>Balanced saline solution irrigation</p></list-item><list-item><p>Sterile surgical drapes</p></list-item><list-item><p>Sterile lid speculum</p></list-item><list-item><p>Superior corneal tractor suture, 7&#x02013;0 silk</p></list-item><list-item><p>Superior fornix-based conjunctival incision</p></list-item><list-item><p>Tenon&#x000b4;s capsule dissection</p></list-item><list-item><p>Episcleral vessels cauterization</p></list-item><list-item><p>Limbus-based triangular scleral flap measurement and marking with caliper (3&#x000d7;3&#x000d7;3 mm)</p></list-item><list-item><p>A 2/3 thickness triangular scleral flap creation with #15 blade</p></list-item><list-item><p>Decompressive paracentesis with 27G needle</p></list-item><list-item><p>Paracentesis ampliation with #11 blade</p></list-item><list-item><p>Micro punch trabeculectomy</p></list-item><list-item><p>Peripheral iridectomy with Vannas scissors</p></list-item><list-item><p>Filtration verification</p></list-item><list-item><p>Scleral flap closure with a simple suture (10&#x02013;0 nylon) at triangle apex</p></list-item><list-item><p>Conjunctival closure with two simple sutures (10&#x02013;0 nylon)</p></list-item><list-item><p>Peribulbar gentamicin (40 mg) and dexamethasone (4 mg)</p></list-item><list-item><p>Antibiotic and steroid ointment in lower fornix (1% chloramphenicol + 0.1% dexamethasone)</p></list-item><list-item><p>Sterile dressing.</p></list-item></list></sec><sec><title>Statistical Analysis</title><p>A Microsoft Excel 16.28 version (190,81202) data base was made. Paired T student double tailed was used for pre- and post-procedure IOP and pre- and post-topical antiglaucomatous medication comparison. An IBMSPSS Statistics 2019 data base was made to execute a Welch-Satterthwaite test used for comparison between residents and attendants&#x02019; groups. <italic>p</italic> value &#x0003c;0.05 was considered statistically significant. Descriptive statistic measures were also taken.</p></sec></sec><sec sec-type="results"><title>R<sc>esults</sc></title><p>Ninety-six eyes (77 patients) that underwent trabeculectomy were included in the analysis. 44.79% were male. Median age was 54.04 &#x000b1; 18.92 years (range 1&#x02013;86). Trabeculectomy was performed unilaterally in 75.32% patients and bilaterally in 24.67%. Preoperative mean IOP was 27.86 &#x000b1; 10 mm Hg.</p><p>Basal (preoperative) characteristics of patients are summarized in <xref rid="T1" ref-type="table">Table 1</xref> and their diagnosis (glaucoma type) in <xref rid="T2" ref-type="table">Table 2</xref>. Significant differences among resident and attendant groups were only found in central corneal thickness and 30&#x000b0; visual field mean deviation.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Patients-basal characteristics</p></caption><table frame="hsides" rules="groups" cellpadding="10" cellspacing="0"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">
<italic>Parameter</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">
<italic>Residents</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">
<italic>Attendants</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">
<italic>p-value</italic>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td><td align="center" valign="top" rowspan="1" colspan="1">53.56 &#x000b1; 16.81</td><td align="center" valign="top" rowspan="1" colspan="1">55.35 &#x000b1; 23.64</td><td align="center" valign="top" rowspan="1" colspan="1">0.73</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Central corneal thickness (&#x003bc;m)</td><td align="center" valign="top" rowspan="1" colspan="1">514.93 &#x000b1; 17.21</td><td align="center" valign="top" rowspan="1" colspan="1">525.46 &#x000b1; 17.62</td><td align="center" valign="top" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Preoperative intraocular pressure (mm Hg)</td><td align="center" valign="top" rowspan="1" colspan="1">27.86 &#x000b1; 8.89</td><td align="center" valign="top" rowspan="1" colspan="1">27.88 &#x000b1; 12.50</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Preoperative topical antiglaucomatous therapy (number of medications)</td><td align="center" valign="top" rowspan="1" colspan="1">2.84 &#x000b1; 0.48</td><td align="center" valign="top" rowspan="1" colspan="1">2.69 &#x000b1; 0.60</td><td align="center" valign="top" rowspan="1" colspan="1">0.27</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cup/disk ratio</td><td align="center" valign="top" rowspan="1" colspan="1">0.81 &#x000b1; 0.19</td><td align="center" valign="top" rowspan="1" colspan="1">0.82 &#x000b1; 0.16</td><td align="center" valign="top" rowspan="1" colspan="1">0.79</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">30&#x000b0;perimetry mean deviation (decibels)</td><td align="center" valign="top" rowspan="1" colspan="1">-21.12 &#x000b1; 8.30</td><td align="center" valign="top" rowspan="1" colspan="1">-16.06 &#x000b1; 7.47</td><td align="center" valign="top" rowspan="1" colspan="1">0.008</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Patients diagnosis</p></caption><table frame="hsides" rules="groups" cellpadding="10" cellspacing="0"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">
<italic>Glaucoma type</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">
<italic>Residents n (%)</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">
<italic>Attendants n (%)</italic>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Narrow angle glaucoma<break/>Primary open-angle glaucoma<break/>Secondary to chronic steroid use glaucoma<break/>Pupillary block glaucoma<break/>Pseudoexfoliative glaucoma<break/>Juvenil glaucoma<break/>Traumatic glaucoma<break/>Congenital glaucoma<break/>Uveitic glaucoma<break/>Acute angle closure glaucoma<break/>Normal tension glaucoma<break/>Neovascular glaucoma<break/>Pseudophakic glaucoma</td><td align="center" valign="top" rowspan="1" colspan="1">25 (35.71)<break/>13 (18.57)<break/>12 (17.14)<break/>4 (5.71)<break/>3 (4.28)<break/>3 (4.28)<break/>2 (2.85)<break/>0<break/>3 (4.28)<break/>1 (1.43)<break/>2 (2.85)<break/>1 (1.43)<break/>1 (1.43)</td><td align="center" valign="top" rowspan="1" colspan="1">10 (38.46)<break/>5 (19.23)<break/>2 (7.69)<break/>1 (3.85)<break/>2 (7.69)<break/>0<break/>1 (3.85)<break/>3 (11.54)<break/>0<break/>1 (3.85)<break/>0<break/>1 (3.85)<break/>0</td></tr></tbody></table></table-wrap><p>Mean basal IOP reduction at 6 weeks, 6 months, and 12 months after trabeculectomy was 15.87 mm Hg (56.96%), 14.42 mm Hg (51.75%), and 14.55 mm Hg (52.22%), respectively, <italic>p</italic> &#x0003c; 0.05.</p><p><xref rid="T3" ref-type="table">Table 3</xref> summarizes mean IOP at different follow-up periods post-trabeculectomy among groups.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Median IOP among different follow-up periods</p></caption><table frame="hsides" rules="groups" cellpadding="10" cellspacing="0"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">
<italic>Median IOP (mm Hg)/follow-up period (resident)</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">
<italic>Median IOP (mm Hg)/follow-up period (attendant)</italic>
</th><th align="center" valign="top" rowspan="1" colspan="1">
<italic>p-value</italic>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">9.48 &#x000b1; 6.93 / 24 hours</td><td align="center" valign="top" rowspan="1" colspan="1">8.23 &#x000b1; 7.38 / 24 hours</td><td align="center" valign="top" rowspan="1" colspan="1">0.46</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9.16 &#x000b1; 4.53 / 72 hours</td><td align="center" valign="top" rowspan="1" colspan="1">9.42 &#x000b1; 3.52 / 72 hours</td><td align="center" valign="top" rowspan="1" colspan="1">0.77</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">11.97 &#x000b1; 6.25 / 6 weeks</td><td align="center" valign="top" rowspan="1" colspan="1">12.07 &#x000b1; 6.27 / 6 weeks</td><td align="center" valign="top" rowspan="1" colspan="1">0.94</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13.62 &#x000b1; 5.10 / 6 months</td><td align="center" valign="top" rowspan="1" colspan="1">12.96 &#x000b1; 3.86 / 6 months</td><td align="center" valign="top" rowspan="1" colspan="1">0.50</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13.53 &#x000b1; 5.64 /12 months</td><td align="center" valign="top" rowspan="1" colspan="1">12.73 &#x000b1; 2.65 / 12 months</td><td align="center" valign="top" rowspan="1" colspan="1">0.36</td></tr></tbody></table></table-wrap><p>An increase of 1.45 mm Hg (12.18%) in mean IOP occurred between 6 weeks and 6 months follow-up (<italic>p</italic> = 0.01). Mean IOP decreased 0.13 mm Hg (0.96%) from 6&#x02013;12 months follow-up (<italic>p</italic> = 0.79). When median IOP at 6 weeks and 12 months was compared there was an increase of 1.24 mm Hg (11%) (<italic>p</italic> = 0.071).</p><p>Cumulative success was 66.66% (30% decrease from basal IOP at 12 months follow-up). Total success was reached in 45.83% (<italic>n</italic> = 44) eyes and partial success in 20.83% (<italic>n</italic> = 20) eyes. Success was not achieved at all in 33.33% (<italic>n</italic> = 32) eyes in which an IOP decrease of at least 30% from basal after 12 months follow-up was not achieved, even with topical antiglaucomatous therapy. Out of 32 eyes, 27 required triple therapy (brimonidine tartrate 0.2% + timolol maleate 0.5% + dorzolamide chloride 2%) and five required triple therapy and cyclocryotherapy for IOP control.</p><p>In 26 eyes, surgery was performed by attendants and a success rate of 69.23% (46.15% total success) was obtained in this group. Seventy eyes whose surgeries were performed by residents had a success rate of 65.71% (45.71% total success) (<italic>p</italic> = 0.86).</p><p>Out of 96 eyes, 51 did not need any topical antiglaucomatous therapy for IOP maintenance after 12 months follow-up. An average of 2.79 &#x000b1; 0.52 topical antiglaucomatous medications were used preoperative and 12 months after trabeculectomy it decreased to an average of 0.89 &#x000b1; 1.10 (<italic>p</italic> &#x0003c; 0.05).</p></sec><sec sec-type="discussion"><title>D<sc>iscussion</sc></title><p>Trabeculectomy effectiveness for IOP decrease is well documented. In this study, a median IOP decrease of 13.31 &#x000b1; 5.02 mm Hg was obtained, similar to reports by Gedde et al.<sup><xref rid="B5" ref-type="bibr">5</xref></sup> (12.6 &#x000b1; 5.9 mm Hg) and Chan et al.<sup><xref rid="B6" ref-type="bibr">6</xref></sup> (11.3 &#x000b1; 4.4 mm Hg). Percentual decrease from basal IOP has been reported of 51.6%<sup><xref rid="B6" ref-type="bibr">6</xref></sup> and in this study it was 52.22%.</p><p>Nilforushan et al.,<sup><xref rid="B1" ref-type="bibr">1</xref></sup> Gedde et al.,<sup><xref rid="B5" ref-type="bibr">5</xref></sup> and Kwong et al.<sup><xref rid="B7" ref-type="bibr">7</xref></sup> reported trabeculectomy success of 85.3%, 63.5%, and 69%, respectively, these data coincide with the present study in which cumulative success was 66.66%. Differences exist in success definition among authors, Nilforushan et al.<sup><xref rid="B1" ref-type="bibr">1</xref></sup> considered a successful trabeculectomy if IOP was 5&#x02013;10 mm Hg with a decrease of at least 20% from basal IOP with or without topical antiglaucomatous therapy and Gedde et al.<sup><xref rid="B5" ref-type="bibr">5</xref></sup> determined a successful procedure when IOP was &#x0003c;21 mm Hg or a 20% IOP decrease from basal and in this study, success was considered as 30% IOP decrease from basal with or without topical antiglaucomatous therapy use (total and partial success).</p><p>Chan et al.<sup><xref rid="B6" ref-type="bibr">6</xref></sup> reported that 50% of their patients required topical antiglaucomatous therapy for IOP control after trabeculectomy (1.2 &#x000b1; 1.5 eye drops), in this study 46.88% required topical therapy (0.89&#x000b1; eye drops). Gedde et al.<sup><xref rid="B5" ref-type="bibr">5</xref></sup> reported a topical antiglaucomatous decrease of 1.7 &#x000b1; 2 eye drops, in this study, general decrease of medication was 1.9 &#x000b1; 0.6 eye drops.</p><p>Previous studies suggest that resident performed trabeculectomies may have outcomes comparable to those in the overall literature, Nilforushan et al.<sup><xref rid="B1" ref-type="bibr">1</xref></sup> reported a trabeculectomy success of 87.8% when performed by residents and 85.3% by attendants, and Biggerstaff et al.<sup><xref rid="B8" ref-type="bibr">8</xref></sup> reported a success rate of 51.6% and 33.1%, respectively. In this study, effectiveness between the two groups showed no significant differences (69.23% for attendants and 65.71% for residents, <italic>p</italic> = 0.86).</p></sec><sec sec-type="conclusion"><title>C<sc>onclusion</sc></title><p>Our data demonstrate that trabeculectomy continues to be a successful and effective therapy to obtain a significant and stable IOP decrease. Another advantage is topical antiglaucomatous therapy decrease that improves patient quality of life. In our training institution, success rates comparing resident performed trabeculectomy to attending performed were similar, so successful trabeculectomies can be performed with proper technique usage and direction and supervision of residents in training.</p></sec></body><back><fn-group><fn id="fn1" fn-type="COI-statement"><p><bold>Source of support:</bold> Nil</p><p><bold>Conflict of interest:</bold> None</p></fn></fn-group><ref-list><title>R<sc>eferences</sc></title><ref id="B1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilforushan</surname><given-names>N</given-names></name><name><surname>Yadhari</surname><given-names>M</given-names></name><name><surname>Astaraki</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><article-title>Comparison of the long&#x02013;term outcomes of resident versus attending performed trabeculectomy.</article-title><source>J Curr Ophthalmol</source><year>2017</year><volume>29</volume><issue>3</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.joco.2017.02.002</pub-id><pub-id pub-id-type="pmid">28367518</pub-id></element-citation></ref><ref id="B2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barr&#x000ed;a</surname><given-names>F</given-names></name><name><surname>Jim&#x000e9;nez-Rom&#x000e1;n</surname><given-names>J</given-names></name></person-group><article-title>Gu&#x000ed;a Latinoamericana de glaucoma primario de &#x000e1;ngulo abierto.</article-title><comment>PAAO</comment><year>2019</year></element-citation></ref><ref id="B3"><label>3.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>D</given-names></name></person-group><part-title>Introduction to Glaucoma Diagnosis.</part-title><person-group person-group-type="editor"><name><surname>Rapuano</surname><given-names>J</given-names></name></person-group><comment>ed. Glaucoma.</comment><publisher-loc>China</publisher-loc><publisher-name>Wolters Kluwer</publisher-name><year>2019</year><fpage>2</fpage><lpage>3</lpage></element-citation></ref><ref id="B4"><label>4.</label><element-citation publication-type="book"><collab>European Glaucoma Society.</collab><part-title>Terminolog&#x000ed;a y pautas para el glaucoma.</part-title><publisher-loc>Eropean Union</publisher-loc><publisher-name>European Glaucoma Society</publisher-name><year>2014</year></element-citation></ref><ref id="B5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gedde</surname><given-names>S</given-names></name><name><surname>Schiffman</surname><given-names>J</given-names></name><name><surname>Feuer</surname><given-names>W</given-names></name><etal>et al.</etal></person-group><article-title>Treatment outcomes in the tube versus trabeculectomy (TVT) study after five years of follow-up.</article-title><source>Am J Ophthalmol</source><year>2012</year><volume>153</volume><issue>5</issue><fpage>789</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2011.10.026</pub-id><pub-id pub-id-type="pmid">22245458</pub-id></element-citation></ref><ref id="B6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Sangami</surname><given-names>P</given-names></name><etal>et al.</etal></person-group><article-title>Primary trabeculectomy surgery performed by residents at a County Hospital.</article-title><source>J Glaucoma</source><year>2007</year><volume>16</volume><issue>1</issue><fpage>52</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1097/01.ijg.0000243473.59084.dd</pub-id><pub-id pub-id-type="pmid">17224750</pub-id></element-citation></ref><ref id="B7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwong</surname><given-names>A</given-names></name><name><surname>Law</surname><given-names>S</given-names></name><name><surname>Kule</surname><given-names>R</given-names></name><etal>et al.</etal></person-group><article-title>Long-term outcomes of resident- versus attending-performed primary trabeculectomy with mitomycin-c in a United States residency program.</article-title><source>Am J Ophthalmol</source><year>2014</year><volume>157</volume><issue>6</issue><fpage>1190</fpage><lpage>1201</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2014.02.028</pub-id><pub-id pub-id-type="pmid">24531023</pub-id></element-citation></ref><ref id="B8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biggerstaff</surname><given-names>K</given-names></name><name><surname>Vincent</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><article-title>Trabeculectomy outcomes by supervised trainees in a Veterans Affairs Medical Center.</article-title><source>J Glaucoma</source><year>2016</year><volume>25</volume><issue>8</issue><fpage>669</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1097/IJG.0000000000000399</pub-id><pub-id pub-id-type="pmid">26950572</pub-id></element-citation></ref></ref-list></back></article>
